Kolchinsky Peter 4
4 · Dicerna Pharmaceuticals Inc · Filed Nov 21, 2019
Insider Transaction Report
Form 4
Kolchinsky Peter
Director10% Owner
Transactions
- Sale
Common Stock
2019-11-20$22.93/sh−265,505$6,088,879→ 1,793,981 total(indirect: See Note) - Sale
Common Stock
2019-11-19$23.92/sh−397,183$9,501,293→ 2,059,486 total(indirect: See Note) - Sale
Common Stock
2019-11-21$22.98/sh−351,505$8,076,952→ 1,442,476 total(indirect: See Note)
Footnotes (8)
- [F1]The securities sold include (a) 337,605 shares of Common Stock by RA Capital Healthcare Fund, L.P. (the "Fund") and (b) 59,578 shares of Common Stock by a separately managed account (the "Account").
- [F2]This transaction was executed in multiple trades at prices ranging from $23.84 to $23.9794; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions, and all other transactions reported in this Form 4, were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
- [F3]RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund and the Account. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP") of which Dr. Peter Kolchinsky is a managing member. Dr. Kolchinsky disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a)(2) under the Exchange Act except to the extent of his pecuniary interest therein.
- [F4]The securities sold include (a) 225,680 shares of Common Stock by the Fund and (b) 39,825 shares of Common Stock by the Account.
- [F5]This transaction was executed in multiple trades at prices ranging from $22.7951 to $22.9756.
- [F6]The securities sold include (a) 298,779 shares of Common Stock by the Fund and (b) 52,726 shares of Common Stock by the Account.
- [F7]This transaction was executed in multiple trades at prices ranging from $22.5711 to $23.0607.
- [F8]Following the reported transactions, the Fund held 1,296,617 shares and the Account held 145,859 shares.